Welcome to our dedicated page for JPMORGAN CHASE & CO SEC filings (Ticker: VYLD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on JPMORGAN CHASE & CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into JPMORGAN CHASE & CO's regulatory disclosures and financial reporting.
JPMorgan Chase & Co. Chairman and CEO James Dimon reported indirect open-market sales totaling 69,512 shares of common stock on February 19, 2026. The shares were sold by family trusts associated with Dimon at prices in the $307.19 per-share range, and he disclaims beneficial ownership except to the extent of any pecuniary interest.
After these sales, the family trusts still held 4,209,284 shares as of the transaction date. Dimon also reported 1,667,862 shares held directly, plus additional indirect holdings through a 401(k), an LLC, and his spouse, indicating a substantial continuing stake in JPMorgan stock.
JPMorgan Chase & Co. filed a Form 144 reporting an intent to sell common stock through J.P. Morgan Securities LLC on 02/19/2026. The filing lists share lots including 15,000 shares acquired 10/13/2017 and 54,512 shares acquired 10/16/2019.
JPMorgan Chase executive Douglas B. Petno, Co-CEO of the Corporate & Investment Bank, reported an open-market sale of company stock. On February 17, 2026, he sold 3,487 shares of JPMorgan Chase common stock at $306.4035 per share. After this trade, he holds 364,828 shares directly and 70,457 shares indirectly through family trusts.
JPMorgan Chase executive Mary E. Erdoes, CEO of Asset & Wealth Management, reported an open-market sale of 5,731 shares of common stock at $306.4118 per share on February 17, 2026. After this transaction, she directly holds 613,405 JPMorgan Chase shares.
JPMorgan Chase & Co.'s Chief Information Officer Lori A. Beer reported an open-market sale of company stock. On February 17, 2026, she sold 2,047 shares of common stock at a price of $306.4031 per share. After this transaction, she directly beneficially owned 60,452 shares of JPMorgan Chase common stock.
JPMorgan Chase & Co. Chief Financial Officer Jeremy Barnum reported an open-market sale of 2,892 shares of common stock on February 17, 2026 at $306.4167 per share. Following this transaction, he directly owned 23,804 shares of JPMorgan Chase common stock.
JPMorgan Chase executive Lake Marianne reported an open-market sale of 3,907 shares of common stock at $306.4137 per share. The transaction was executed on February 17, 2026 through Grantor Retained Annuity Trusts, which hold 137,299 shares indirectly after the sale.
Separately from these GRAT holdings, she is shown with 48,017 shares held directly and 64,271 shares held indirectly through a Family Trust. Footnote disclosures explain earlier February 2026 transfers among a GRAT, a Family Trust, and the Grantor that were treated as exempt under Rule 16a-13.
JPMorgan Chase & Co. General Counsel Stacey Friedman reported an indirect sale of common stock through a grantor retained annuity trust (GRAT). On February 17, 2026, the GRAT sold 3,404 shares at $306.3999 per share in an open-market transaction.
Following this sale, the GRAT held 61,949 shares of JPMorgan Chase common stock indirectly for Friedman. Separately, she held 50,136 shares directly, and an additional 13,604 shares were held indirectly in a trust.
JPMorgan Chase insider Stacey Friedman has filed a Form 144 indicating an intent to sell 3,404 shares of common stock. The planned sale, through J.P. Morgan Securities LLC on the NYSE, has an aggregate market value of 1,042,985.11 based on the filing.
The shares to be sold were originally acquired on 03/25/2022 as equity compensation awards from the issuer. The filing also notes a prior sale of 3,404 shares of common stock on 01/16/2026, which generated gross proceeds of 1,064,758. Shares outstanding were 2,696,272,576 as of the figures used in the notice.
A shareholder filed a Form 144 notice to sell 3,907 shares of common stock, with an aggregate market value of $1,197,158.15. The shares are to be sold through J.P. Morgan Securities LLC on the NYSE around 02/17/2026. These shares were acquired on 01/13/2022 as equity compensation awards from the issuer. The filer also sold 3,908 shares of the same common stock on 01/16/2026 for gross proceeds of $1,222,353.41, as disclosed for sales during the past three months.